menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack 

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Details
Comments
  • Overview

    Dr. Marie-Sophie de Konig reviews the findings of the GIPS-IV trial, which was the first study to test the use of sodium thiosulfate for treating myocardial infarction in humans. 

Facebook Comments

Recommended
Details
Comments
  • Overview

    Dr. Marie-Sophie de Konig reviews the findings of the GIPS-IV trial, which was the first study to test the use of sodium thiosulfate for treating myocardial infarction in humans. 

Facebook Comments

Schedule5 Dec 2022